Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients

The AGE–RAGE Pathway and Its Relation to Cardiovascular Disease in Patients with Chronic Kidney Disease

(2013) Paul Leurs et al.   ARCHIVES OF MEDICAL RESEARCH

sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death

(2013) E. Selvin et al.   DIABETES

RAGE regulation and signaling in inflammation and beyond

(2013) Katrin Kierdorf et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Etiology of the Protein-Energy Wasting Syndrome in Chronic Kidney Disease: A Consensus Statement From the International Society of Renal Nutrition and Metabolism (ISRNM)

(2013) Juan Jesús Carrero et al.   JOURNAL OF RENAL NUTRITION

S100A12 Gene Expression Is Increased in Peripheral Leukocytes in Chronic Kidney Disease Stage 4-5 Patients with Cardiovascular Disease

(2013) Masaki Hara et al.   NEPHRON CLINICAL PRACTICE

Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease – a prospective observational study

(2013) Martina Peiskerová et al.   BMC Nephrology

EN-RAGE (extracellular newly identified receptor for advanced glycation end-products binding protein) and mortality of long-term hemodialysis patients: Aprospective observational cohort study

(2012) Marta Kalousová et al.   CLINICAL BIOCHEMISTRY

Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled

(2012) Usama Elewa et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

(2012) Caroline S Fox et al.   LANCET

Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis

(2011) Jwa-Kyung Kim et al.   ATHEROSCLEROSIS

Plasma S100A12 Level Is Associated with Cardiovascular Disease in Hemodialysis Patients

(2011) Y. Shiotsu et al.   Clinical Journal of the American Society of Nephrology

Cardiovascular Biomarkers in Chronic Kidney Disease

(2011) Sun-Hee Park et al.   JOURNAL OF RENAL NUTRITION

Serum S100A12 (EN-RAGE) Levels in Patients with Decreased Renal Function and Subclinical Chronic Inflammatory Disease

(2011) Oskar Zakiyanov et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients

(2010) A. Nakashima et al.   Clinical Journal of the American Society of Nephrology

RAGE and cardiovascular disease

(2010) Chi Young Shim   Frontiers in Bioscience-Landmark

Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever

(2009) T. Kallinich et al.   ANNALS OF THE RHEUMATIC DISEASES

Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease

(2009) Nitin Mahajan et al.   ATHEROSCLEROSIS

C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: Inhibitory effects of atorvastatin

(2009) Nitin Mahajan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis

(2008) Yasukiyo Mori et al.   AMERICAN JOURNAL OF NEPHROLOGY

Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?

(2008) P. Stenvinkel et al.   Clinical Journal of the American Society of Nephrology

Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function

(2008) Tomohito Gohda et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Topological research on diamagnetic susceptibilities of organic compounds

(2008) Lailong Mu et al.   JOURNAL OF MOLECULAR MODELING

Plasma S100A12 Concentrations in Peritoneal Dialysis Patients and Subclinical Chronic Inflammatory Disease

(2008) Yoko Uchiyama-Tanaka et al.   THERAPEUTIC APHERESIS AND DIALYSIS

A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

(2007) D. Fouque et al.   KIDNEY INTERNATIONAL